{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:57:59Z","timestamp":1792598279327,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,4,11]],"date-time":"2012-04-11T00:00:00Z","timestamp":1334102400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1038\/pr.2012.51","type":"journal-article","created":{"date-parts":[[2012,4,11]],"date-time":"2012-04-11T11:56:58Z","timestamp":1334145418000},"page":"43-49","source":"Crossref","is-referenced-by-count":61,"title":["A seven-day study of the pharmacokinetics of intravenous levetiracetam in neonates: marked changes in pharmacokinetics occur during the first week of life"],"prefix":"10.1038","volume":"72","author":[{"given":"Cynthia M.","family":"Sharpe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmund V.","family":"Capparelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Mower","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Farrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J.","family":"Soldin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard H.","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,4,11]]},"reference":[{"key":"BFpr201251_CR1","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1212\/01.WNL.0000157320.78071.6D","volume":"64","author":"R Sankar","year":"2005","unstructured":"Sankar R, Painter MJ . Neonatal seizures: after all these years we still love what doesn\u2019t work. Neurology 2005;64:776\u20137.","journal-title":"Neurology"},{"key":"BFpr201251_CR2","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0887-8994(02)00621-5","volume":"28","author":"MS Scher","year":"2003","unstructured":"Scher MS, Alvin J, Gaus L, Minnigh B, Painter MJ . Uncoupling of EEG-clinical neonatal seizures after antiepileptic drug use. Pediatr Neurol 2003;28:277\u201380.","journal-title":"Pediatr Neurol"},{"key":"BFpr201251_CR3","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1056\/NEJM199908123410704","volume":"341","author":"MJ Painter","year":"1999","unstructured":"Painter MJ, Scher MS, Stein AD, et al. Phenobarbital compared with phenytoin for the treatment of neonatal seizures. N Engl J Med 1999;341:485\u20139.","journal-title":"N Engl J Med"},{"key":"BFpr201251_CR4","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1177\/000992289903800702","volume":"38","author":"S Sulzbacher","year":"1999","unstructured":"Sulzbacher S, Farwell JR, Temkin N, Lu AS, Hirtz DG . Late cognitive effects of early treatment with phenobarbital. Clin Pediatr (Phila) 1999;38:387\u201394.","journal-title":"Clin Pediatr (Phila)"},{"key":"BFpr201251_CR5","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1111\/j.1600-0404.1990.tb01008.x","volume":"81","author":"EP Calandre","year":"1990","unstructured":"Calandre EP, Dominguez-Granados R, Gomez-Rubio M, Molina-Font JA . Cognitive effects of long-term treatment with phenobarbital and valproic acid in school children. Acta Neurol Scand 1990;81:504\u20136.","journal-title":"Acta Neurol Scand"},{"key":"BFpr201251_CR6","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S0022-3476(79)80507-7","volume":"95","author":"CS Camfield","year":"1979","unstructured":"Camfield CS, Chaplin S, Doyle AB, Shapiro SH, Cummings C, Camfield PR . Side effects of phenobarbital in toddlers; behavioral and cognitive aspects. J Pediatr 1979;95:361\u20135.","journal-title":"J Pediatr"},{"key":"BFpr201251_CR7","doi-asserted-by":"publisher","first-page":"15089","DOI":"10.1073\/pnas.222550499","volume":"99","author":"P Bittigau","year":"2002","unstructured":"Bittigau P, Sifringer M, Genz K, et al. Antiepileptic drugs and apoptotic neurodegeneration in the developing brain. Proc Natl Acad Sci USA 2002;99:15089\u201394.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFpr201251_CR8","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.expneurol.2005.01.006","volume":"193","author":"D Manthey","year":"2005","unstructured":"Manthey D, Asimiadou S, Stefovska V, et al. Sulthiame but not levetiracetam exerts neurotoxic effect in the developing rat brain. Exp Neurol 2005;193:497\u2013503.","journal-title":"Exp Neurol"},{"key":"BFpr201251_CR9","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3233\/JPN-2009-0275","volume":"7","author":"C Sharpe","year":"2009","unstructured":"Sharpe C, Haas RH . Levetiracetam in the treatment of neonatal seizures. J Pediatr Neurol 2009;7:79\u201383.","journal-title":"J Pediatr Neurol"},{"key":"BFpr201251_CR10","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1177\/0883073807309781","volume":"23","author":"P Krief","year":"2008","unstructured":"Krief P, Li Kan, Maytal J . Efficacy of levetiracetam in children with epilepsy younger than 2 years of age. J Child Neurol 2008;23:582\u20134.","journal-title":"J Child Neurol"},{"key":"BFpr201251_CR11","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.seizure.2010.01.003","volume":"19","author":"A F\u00fcrwentsches","year":"2010","unstructured":"F\u00fcrwentsches A, Bussmann C, Ramantani G, et al. Levetiracetam in the treatment of neonatal seizures: a pilot study. Seizure 2010;19:185\u20139.","journal-title":"Seizure"},{"key":"BFpr201251_CR12","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1177\/0883073807299973","volume":"22","author":"MT Shoemaker","year":"2007","unstructured":"Shoemaker MT, Rotenberg JS . Levetiracetam for the treatment of neonatal seizures. J Child Neurol 2007;22:95\u20138.","journal-title":"J Child Neurol"},{"key":"BFpr201251_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejpn.2010.10.003","volume":"15","author":"G Ramantani","year":"2011","unstructured":"Ramantani G, Ikonomidou C, Walter B, Rating D, Dinger J . Levetiracetam: safety and efficacy in neonatal seizures. Eur J Paediatr Neurol 2011;15:1\u20137.","journal-title":"Eur J Paediatr Neurol"},{"key":"BFpr201251_CR14","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.pediatrneurol.2010.11.005","volume":"44","author":"O Khan","year":"2011","unstructured":"Khan O, Chang E, Cipriani C, Wright C, Crisp E, Kirmani B . Use of intravenous levetiracetam for management of acute seizures in neonates. Pediatr Neurol 2011;44:265\u20139.","journal-title":"Pediatr Neurol"},{"key":"BFpr201251_CR15","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1177\/0883073810384263","volume":"26","author":"NS Abend","year":"2011","unstructured":"Abend NS, Gutierrez-Colina AM, Monk HM, Dlugos DJ, Clancy RR . Levetiracetam for treatment of neonatal seizures. J Child Neurol 2011;26:465\u201370.","journal-title":"J Child Neurol"},{"key":"BFpr201251_CR16","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.pediatrneurol.2008.04.008","volume":"39","author":"FS Silverstein","year":"2008","unstructured":"Silverstein FS, Ferriero DM . Off-label use of antiepileptic drugs for the treatment of neonatal seizures. Pediatr Neurol 2008;39:77\u20139.","journal-title":"Pediatr Neurol"},{"key":"BFpr201251_CR17","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.jpeds.2011.03.057","volume":"159","author":"SL Merhar","year":"2011","unstructured":"Merhar SL, Schibler KR, Sherwin CM, et al. Pharmacokinetics of levetiracetam in neonates with seizures. J Pediatr 2011;159:152\u2013154.e3.","journal-title":"J Pediatr"},{"key":"BFpr201251_CR18","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1111\/j.1528-1167.2007.01090.x","volume":"48","author":"TA Glauser","year":"2007","unstructured":"Glauser TA, Mitchell WG, Weinstock A, et al. Pharmacokinetics of levetiracetam in infants and young children with epilepsy. Epilepsia 2007;48:1117\u201322.","journal-title":"Epilepsia"},{"key":"BFpr201251_CR19","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1046\/j.1528-1157.2001.41300.x","volume":"42","author":"JM Pellock","year":"2001","unstructured":"Pellock JM, Glauser TA, Bebin EM, et al. Pharmacokinetic study of levetiracetam in children. Epilepsia 2001;42:1574\u20139.","journal-title":"Epilepsia"},{"key":"BFpr201251_CR20","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.eplepsyres.2006.12.005","volume":"74","author":"NB Fountain","year":"2007","unstructured":"Fountain NB, Conry JA, Rodr\u00edguez-Leyva I, et al. Prospective assessment of levetiracetam pharmacokinetics during dose escalation in 4- to 12-year-old children with partial-onset seizures on concomitant carbamazepine or valproate. Epilepsy Res 2007;74:60\u20139.","journal-title":"Epilepsy Res"},{"key":"BFpr201251_CR21","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1111\/j.1528-1167.2008.01974.x","volume":"50","author":"S Chhun","year":"2009","unstructured":"Chhun S, Jullien V, Rey E, Dulac O, Chiron C, Pons G . Population pharmacokinetics of levetiracetam and dosing recommendation in children with epilepsy. Epilepsia 2009;50:1150\u20137.","journal-title":"Epilepsia"},{"key":"BFpr201251_CR22","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s00467-008-0997-5","volume":"24","author":"MM Rhodin","year":"2009","unstructured":"Rhodin MM, Anderson BJ, Peters AM, et al. Human renal function maturation: a quantitative description using weight and postmenstrual age. Pediatr Nephrol 2009;24:67\u201376.","journal-title":"Pediatr Nephrol"},{"key":"BFpr201251_CR23","doi-asserted-by":"publisher","first-page":"707","DOI":"10.2165\/00003088-200443110-00002","volume":"43","author":"PN Patsalos","year":"2004","unstructured":"Patsalos PN . Clinical pharmacokinetics of levetiracetam. Clin Pharmacokinet 2004;43:707\u201324.","journal-title":"Clin Pharmacokinet"},{"key":"BFpr201251_CR24","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1046\/j.1528-1157.2003.25302.x","volume":"44","author":"R Coupez","year":"2003","unstructured":"Coupez R, Nicolas JM, Browne TR . Levetiracetam, a new antiepileptic agent: lack of in vitro and in vivo pharmacokinetic interaction with valproic acid. Epilepsia 2003;44:171\u20138.","journal-title":"Epilepsia"},{"key":"BFpr201251_CR25","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.pediatrneurol.2010.05.008","volume":"43","author":"MG Dahlin","year":"2010","unstructured":"Dahlin MG, Wide K, Ohman I . Age and comedications influence levetiracetam pharmacokinetics in children. Pediatr Neurol 2010;43:231\u20135.","journal-title":"Pediatr Neurol"},{"key":"BFpr201251_CR26","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0014-2999(98)00410-5","volume":"353","author":"H Klitgaard","year":"1998","unstructured":"Klitgaard H, Matagne A, Gobert J, W\u00fclfert E . Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy. Eur J Pharmacol 1998;353:191\u2013206.","journal-title":"Eur J Pharmacol"},{"key":"BFpr201251_CR27","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1684\/j.1950-6945.2000.tb00363.x","volume":"2","author":"P Genton","year":"2000","unstructured":"Genton P, Van Vleymen B . Piracetam and levetiracetam: close structural similarities but different pharmacological and clinical profiles. Epileptic Disord 2000;2:99\u2013105.","journal-title":"Epileptic Disord"},{"key":"BFpr201251_CR28","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1111\/j.1528-1167.2010.02519.x","volume":"51","author":"DT Depositario-Cabacar","year":"2010","unstructured":"Depositario-Cabacar DT, Peters JM, Pong AW, et al. High-dose intravenous levetiracetam for acute seizure exacerbation in children with intractable epilepsy. Epilepsia 2010;51:1319\u201322.","journal-title":"Epilepsia"},{"key":"BFpr201251_CR29","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.pediatrneurol.2010.08.014","volume":"44","author":"MR Zimbric","year":"2011","unstructured":"Zimbric MR, Sharpe CM, Albright KC, Nespeca MP . Three-channel electroencephalogram montage in neonatal seizure detection and quantification. Pediatr Neurol 2011;44:31\u20134.","journal-title":"Pediatr Neurol"},{"key":"BFpr201251_CR30","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.clinbiochem.2009.11.008","volume":"43","author":"DR Mendu","year":"2010","unstructured":"Mendu DR, Soldin SJ . Simultaneous determination of levetiracetam and its acid metabolite (ucb L057) in serum\/plasma by liquid chromatography tandem mass spectrometry. Clin Biochem 2010;43:485\u20139.","journal-title":"Clin Biochem"},{"key":"BFpr201251_CR31","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0169-2607(98)00098-4","volume":"59","author":"J Parke","year":"1999","unstructured":"Parke J, Holford NH, Charles BG . A procedure for generating bootstrap samples for the validation of nonlinear mixed-effects population models. Comput Methods Programs Biomed 1999;59:19\u201329.","journal-title":"Comput Methods Programs Biomed"}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/pr201251.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/pr201251","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/pr201251.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T22:55:33Z","timestamp":1713826533000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/pr201251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,11]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["BFpr201251"],"URL":"https:\/\/doi.org\/10.1038\/pr.2012.51","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,11]]}}}